Watson David Hibbert sold $7.8M of AGX

Watson David Hibbert (PRESIDENT AND CEO) sold 11,873 shares of ARGAN INC (AGX) at an average of $660.11 ($651.22–$707.35, $7.84M total) across 2 trades over 2026-06-15 to 2026-06-16.

Original reporting
SEC EDGAR · Watson David Hibbert
Published Jun 16, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AGX
Bearish
medium confidence
Mentioned
$AGX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AGXBearishLow
01

Why it matters

A CEO open-market sale of $7.84M can influence short-term sentiment, especially because no 10b5-1 plan is indicated, but it does not provide new information about earnings, guidance, contracts, or operations.

02

Market read

Traders may reassess near-term sentiment and positioning in AGX following the CEO’s disclosed selling activity.

03

What to watch

The filing does not state the reason for the sale; also, the absence of a stated 10b5-1 plan may be less informative than investors assume without additional context.

Relevance 6/10Novelty 8/10Timing: Filed 2026-06-16; sale executed 2026-06-15 to 2026-06-16.

Background

The article is an SEC Form 4 insider transaction disclosure for ARGAN Inc (AGX).

Company-level read

Ticker impact

$AGXBearishMedium confidence
Context

SEC Form 4 shows AGX CEO Watson David Hibbert sold $7.84M of AGX shares in two open-market trades (6/15–6/16).

Expected impact

Likely modest negative bias for AGX shares around the filing/next sessions; magnitude uncertain because the sale is not tied to a disclosed catalyst.

Evidence & confidence

The article discloses a large CEO open-market sale ($7.84M) with no 10b5-1 plan stated, which can increase investor concern, though Form 4 sales are often routine and lack direct operational implications.

Market effects

Limited sector read-through; this is company-specific insider activity rather than an industry catalyst.

No clear regional spillover indicated by the filing details.

Minimal global relevance; disclosure is confined to AGX insider transactions.

Counterpoint

The sale could be for diversification/tax/financing needs and does not necessarily reflect a bearish view of AGX fundamentals.

Key entities

  • ARGAN INC

    Company whose shares were sold by its CEO in the disclosed Form 4 transactions.

  • Watson David Hibbert

    ARGAN Inc President and CEO who sold shares in two open-market trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AGXMed

Silver X Files NI 43-101 Technical Report for the Updated Nueva Recuperada Mineral Resource: 10.4 Mt Measured and Indicated at 202 g/t AgEq (67.3 Moz AgEq) and 21.6 Mt Inferred at 260 g/t AgEq (184.3 Moz AgEq)

Silver X Mining Corp. (AGX) filed an updated NI 43-101 technical report for its Nueva Recuperada project in Peru, showing increased mineral resources. Measured and Indicated resources total 10.4 Mt with 67.3 Moz AgEq, up 107% from the previous estimate. Inferred resources total 21.6 Mt with 184.3 Moz AgEq. The report includes revisions from the September 22, 2026 news release, with no change in tonnage or classification. The company plans to expand its mining operations and plant capacity.

$AGXMedAI 8/10

Argan’s (AGX) Power Boom Comes With A Margin Catch

Argan (AGX) reported record Q2 revenue of $384.0M (+61.5% YoY) and net income of $53.3M, driven by its Power segment. Gross margin slipped to 19.3%, and backlog decreased to $2.5B. The company is debt-free with $1.03B in cash, returning $51.7M to shareholders. Management expects new projects but faces regulatory challenges and margin compression.

$AGXMed

Argan (AGX) Q2 2027 Earnings Call Transcript

Argan (AGX) reported Q2 2027 revenue of $384.0M, up 61.5%, with net income of $53.3M ($3.76 per diluted share). Power segment revenue grew 53% YoY to $301M, while Industrial segment revenue rose 111% to $76M. Consolidated backlog decreased to $2.5B. The company plans to complete a new fabrication facility in North Carolina by Q3 2027.